

| Descargas | ||
Ciprofloxacin Single-Dose Otic Solution |
Publications |
|
![]() |
Acute otitis externa even when the status of the tympanic membrane is unknown. Chronic suppurative otitis media, the only approved otic solution for this indication; represents 85% of otitis prescriptions with an incidence of 1.5% of the adult population. Indicated also in paediatrics use (no systemic absorption). An excellent topical use alternative. Easy use-single dose units. Wide anti-bacterial spectrum with high efficacy for Pseudomonas and Staphylos. |
|
|
|
|
Products protected by valid patents are developed with no commercial purposes. These products are under development or study for internal or experimental uses as permitted by the Art. 10.6 of the Directive 2001/83/EC amended by Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004.
None of the products are offered for sale or supplied to countries in which these acts could be in conflict with valid patents.
© All rights reserved. Invent Farma Group.